Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R)
- Details
- Category: Product
![Pharmion Pharmion](http://www.worldpharmanews.com/images/stories/logo/pharmion.gif)
Pfizer Wins Key New York State Court Ruling on Celebrex
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Roche engages in four additional AIDS Technology Transfers
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Expanded Labeling for MabCampath® in Europe
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
More Pharma News ...
- New pharmaceutical candidate Lu AA37096 enters Lundbeck's development pipeline
- Pfizer Completes Sale of Consumer Healthcare Business
- Galvus®, a new oral treatment for type 2 diabetes, receives positive opinion
- Pfizer to Acquire CovX to Extend Biotherapeutics Investment
- European Commission Approves ATRIPLA®
- Avista Capital Partners to Acquire Bristol-Myers Squibb Medical Imaging for $525 Million
- Novo Nordisk licenses global rights to potential new haemostasis therapy